KLF5 and triple-negative breast carcinoma: PVT1 could also enhance the stability of Kruppel-like factor 5 (KLF5) and increase the expression of β-catenin, an important downstream effector of KLF5, to promote tumorigenesis in triple-negative breast cancer (110).